Persistent Disease
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Brivanib Alaninate in Treating Patients With Persistent or Recurrent Cervical Cancer (NCT01267253) | Gynecologic Oncology Group | 2011-04-04 |
Track Persistent Disease automatically
Every clearance here is in the API, with alerts when new ones post.